The future of novel endpoints in cancer care | ZS

Insights

Novel Endpoints in Cancer Care: What Lies Ahead

Malik Kaman

Malik Kaman, Associate Principal, Oncology, ZS Associates, sits down with Lee S. Schwartzberg, MD, Executive Director, West Cancer Center, Chief, Professor of Medicine, Division of Hematology/Oncology, the University of Tennessee Health Science Center, to discuss what lies ahead for novel endpoints in cancer care.



Related Videos


CAR-T Center and Patients

How Can a CAR-T Center Get Established and Effectively Treat Patients



Manufacturers and CAR-T

How Can Manufacturers Help Institutions Prepare for CAR-T Therapies



Future of CAR-T therapies

Will Tomorrow's CAR-T Therapy Innovations Solve Today's Challenges


Next-Gen Sequencing

Next-Gen Sequencing is Transforming Oncology Practices



NGS-Based Cancer Tests

Will NGS Based Cancer Tests Become Routine




Hazards of Misinformation



Oncology Clinical Trials



Future of Cancer Care